- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- February 2024
- 185 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- August 2024
- 80 Pages
Global
From €3500EUR$3,926USD£3,029GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
- Book
- July 2023
- 1568 Pages
Esmolol is a cardiovascular drug used to treat rapid heart rate and hypertension. It is a beta-blocker, meaning it works by blocking the action of certain natural chemicals in the body, such as epinephrine, that affect the heart and blood vessels. Esmolol is used to treat rapid heart rate and hypertension, and is also used to prevent and treat irregular heartbeats. It is available in both injectable and oral forms.
Esmolol is a widely used drug in the cardiovascular market, and is often prescribed in combination with other drugs to treat heart conditions. It is also used in the treatment of atrial fibrillation, a condition in which the heart beats irregularly.
The market for Esmolol is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more